HRB presents TiGER during SVPW symposium

This Friday, Kitty Huijben will be giving a talk at the Society for Plant Biotechnology and Tissue Culture Symposium (https://www.svpw.nl/) about our TiGER-workflow 🐯 “A transgene-free CRISPR Workflow for genome-edited plants in a single generation.” For a wide range of species, our TiGER workflow overcomes #CRISPR bottlenecks to rapidly deliver top-quality products that can be directly introduced into the […]

CRISPR’s role in mushroom safety: towards antidote discovery

Not yet the season of mushrooms 🍄, but an interesting read on how CRISPR can help preventing deaths from eating the wrong mushroom. 🍄 The Amanita phalloides/death cap/’groene knolamaniet’ is very toxic, and unfortunately looks a lot like the Parasol Mushroom and the younger version looks like the button mushroom. A mistake is easily made. […]

HRB INSIGHTS – R&D Optimization & Automation

Hudson River Biotechnology is an innovation-oriented company, with many brilliant scientists in the team. So how do we create an environment where our scientists can perform necessary project tasks, enjoy their work, AND have the time and energy to innovate? Our Innovation & Automation managers, Kitty Huijben & Judit Hunyadkürti wrote down what we’re doing at HRB to make […]

HRB applies for patent for targeted delivery of crop care products and biologicals

March 15, Wageningen – To combat the current issues prevalent in field crop care, HRB and SE collaborated on PlentranceTM: a targeted, biodegradable particle for crop inputs, which can uniquely penetrate the plant cell wall and deliver cargo inside plant cells. Ferdinand Los (CSO): “Originally tailored for CRISPR delivery as part of TiGER genome editing […]

Prof. Enrico Mastrobattista joins Hudson River Biotechnology’s Scientific Advisory Board and will advise on nanoparticle delivery

Professor Enrico Mastrobattista, full professor of Pharmaceutical Biotechnology & Delivery at the department of Pharmaceutical Sciences of Utrecht University, joins the Scientific Advisory Board of Hudson River Biotechnology (HRB). Prof. Mastrobattista’s expertise lies in drug delivery, pharmaceutical biotechnology and nanobiotechnology. He currently leads a research program to develop biomimetic drug delivery systems for the targeted […]

Computomics and Hudson River Biotechnology Collaborate in Optimizing Plant Breeding with CRISPR

Computomics and Hudson River Biotechnology (HRB) will start offering AccelATrait™, a joint end-to-end solution using CRISPR-based gene editing for novel plant trait development. AccelATrait™ uses tailormade machine learning and CRISPR gene editing technologies to deliver new crop varieties with desired traits. AccelATrait™ covers the entire workflow from experimental design to plant regeneration. It helps plant […]

Prof. Patricia Dankers joins Hudson River Biotechnology’s Scientific Advisory Board

Prof. Patricia Dankers, full professor of Biomedical Materials & Chemistry at the department of Biomedical Engineering and the Institute for Complex Molecular Systems of Eindhoven University of Technology, has joined the Scientific Advisory Board of Hudson River Biotechnology (HRB). Prof. Dankers is internationally renowned for her fundamental research on supramolecular biomaterials for regenerative medicine applications. […]

Hudson River Biotechnology raises €5m Series A funding to accelerate growth of its plant gene editing business and expand into nanoparticles for use in field applications

Ferdinand Los, CSO at Hudson River Biotechnology: “We strongly believe in our ability to keep innovating and be at the forefront of technological developments. This funding is another building block, which will allow us to further scale up the existing gene editing business.” Additionally, HRB will grow its staff count from 25 to 40 in […]